Determinants of mean platelet volume (MPV) in an elderly population: Relevance of body fat, blood glucose and ischaemic electrocardiographic changes

Thrombosis and Haemostasis

Volumn 99, Issue 6, 2008, Pages 1079-1084

  Muscari, Antonio ^a,c   De Pascalis, Susanna ^a   Cenni, Andrea ^a   Ludovico, Cosimo ^a   Castaldini, Nicola ^a   Antonelli, Serafina ^b   Bianchi, Giampaolo ^a   Magalotti, Donatella ^a   Zoli, Marco ^a  

^a UNIVERSITY OF BOLOGNA   (Italy)

^b Azienda USL di Bologna   (Italy)

^c UNIVERSITY OF BOLOGNA   (Italy)

Author keywords

Diabetes mellitus; Elderly; Ischaemic heart disease; Mean platelet volume; Obesity

Indexed keywords

GLUCOSE;

ABDOMINAL SUBCUTANEOUS FAT; AGED; ARTICLE; BODY FAT; CARDIOVASCULAR RISK; ECHOGRAPHY; ELECTROCARDIOGRAPHY; FATTY LIVER; FEMALE; GLUCOSE BLOOD LEVEL; HUMAN; INTRAABDOMINAL FAT; LOGISTIC REGRESSION ANALYSIS; MAJOR CLINICAL STUDY; MALE; OBESITY; PRIORITY JOURNAL; SKINFOLD THICKNESS; THROMBOCYTE VOLUME;

ADIPOSITY; AGE FACTORS; AGED; AGING; BLOOD GLUCOSE; BLOOD PLATELETS; CARDIOVASCULAR DISEASES; CELL SIZE; CROSS-SECTIONAL STUDIES; DIABETES MELLITUS; ELECTROCARDIOGRAPHY; FEMALE; HUMANS; ITALY; LOGISTIC MODELS; MALE; MYOCARDIAL ISCHEMIA; OBESITY; ODDS RATIO; RISK ASSESSMENT; RISK FACTORS;

EID: 44949092445     PISSN: 03406245     EISSN: None     Source Type: Journal    
DOI: 10.1160/TH07-12-0712     Document Type: Article

References (50)

1. Cameron HA, Phillips R, Ibbotson RM, et al. Platelet size in myocardial infarction. Br Med J (Clin Res Ed) 1983; 287: 449-451.
2. Kilicli-Camur N, Demirtunc R, Konuralp C, et al. Could mean platelet volume be a predictive marker for acute myocardial infarction? Med Sci Monit 2005; 11: CR387-392.
3. Martin JF, Bath PM, Burr ML. Influence of platelet size on outcome after myocardial infarction. Lancet 1991; 338: 1409-1411.
4. Pizzulli L, Yang A, Martin JF, et al. Changes in platelet size and count in unstable angina compared to stable angina or non-cardiac chest pain. Eur Heart J 1998; 19: 80-84.
5. O'Malley T, Langhorne P, Elton RA, et al. Platelet size in stroke patients. Stroke 1995; 26: 995-999.
6. Greisenegger S, Endler G, Hsieh K, et al. Is elevated mean platelet volume associated with a worse outcome in patients with acute ischemic cerebrovascular events? Stroke 2004; 35: 1688-1691.
7. Bath P, Algert C, Chapman N, et al. PROGRESS Collaborative Group. Association of mean platelet volume with risk of stroke among 3134 individuals with history of cerebrovascular disease. Stroke 2004; 35: 622-626.
8. van der Loo B, Martin JF. Megakaryocytes and platelets in vascular disease. Baillieres Clin Haematol 1997; 10: 109-123.
9. Thompson CB, Jakubowski JA, Quinn PG, et al. Platelet size as a determinant of platelet function. J Lab Clin Med 1983; 101: 205-213.
10. Bath PM, Butterworth RJ. Platelet size: measurement, physiology and vascular disease. Blood Coagul Fibrinolysis 1996; 7: 157-161.
11. Yilmaz MB, Saricam E, Biyikoglu SF, et al. Mean platelet volume and exercise stress test. J Thromb Thrombolysis 2004; 17: 115-120.
12. Hendra TJ, Oswald GA, Yudkin JS. Increased mean platelet volume after acute myocardial infarction relates to diabetes and to cardiac failure. Diabetes Res Clin Pract 1988; 5: 63-69.
13. Sharpe PC, Trinick T. Mean platelet volume in diabetes mellitus. Q J Med 1993; 86: 739-742.
14. Hekimsoy Z, Payzin B, Ornek T, et al. Mean platelet volume in Type 2 diabetic patients. J Diabetes Complications 2004; 18: 173-176.
15. Papanas N, Symeonidis G, Maltezos E, et al. Mean platelet volume in patients with type 2 diabetes mellitus. Platelets 2004; 15: 475-478.
16. Kario K, Matsuo T, Nakao K. Cigarette smoking increases the mean platelet volume in elderly patients with risk factors for atherosclerosis. Clin Lab Haematol 1992; 14: 281-1287.
17. Coban E, Yazicioglu G, Berkant Avci A, et al. The mean platelet volume in patients with essential and white coat hypertension. Platelets 2005; 16: 435-438.
18. Coban E, Ozdogan M, Yazicioglu G, et al. The mean platelet volume in patients with obesity. Int J Clin Pract 2005; 59: 981-982.
19. Coban E Md, Afacan B. The effect of rosuvastatin treatment on the mean platelet volume in patients with uncontrolled primary dyslipidemia with hypolipidemic diet treatment. Platelets 2007; 1-4.
20. Muscari A, Antonelli S, Bianchi G, et al. Serum C3 is a stronger inflammatory marker of insulin resistance than C-reactive protein, leukocyte count, and erythrocyte sedimentation rate: comparison study in an elderly population. Diabetes Care 2007; 30: 2362-2368.
21. Expert Panel on Detection, Evaluation, and Treatment of High Blood Cholesterol in Adults. Executive Summary of The Third Report of The National Cholesterol Education Program (NCEP) Expert Panel on Detection, Evaluation, And Treatment of High Blood Cholesterol In Adults (Adult Treatment Panel III). J Am Med Assoc 2001; 285: 2486-2497.
22. Durnin JV, Womersley J. Body fat assessed from total body density and its estimation from skinfold thickness: measurements on 481 men and women aged from 16 to 72 years. Br J Nutr 1974; 32: 77-97.
23. Joseph AE, Saverymuttu SH, al-Sam S, et al. Comparison of liver histology with ultrasonography in assessing diffuse parenchymal liver disease. Clin Radiol 1991; 43: 26-31.
24. Endler G, Klimesch A, Sunder-Plassmann H, et al. Mean platelet volume is an independent risk factor for myocardial infarction but not for coronary artery disease. Br J Haematol 2002; 117: 399-404.
25. Matthews DR, Hosker JP, Rudenski AS, et al. Homeostasis model assessment: insulin resistance and beta-cell function from fasting plasma glucose and insulin concentrations in man. Diabetologia 1985; 28: 412-419.
26. Coban E, Bostan F, Ozdogan M. The mean platelet volume in subjects with impaired fasting glucose. Platelets 2006; 17: 67-69.
27. Coban E, Yilmaz A, Sari R. The effect of weight loss on the mean platelet volume in obese patients. Platelets 2007; 18: 212-216.
28. Senaran H, Ileri M, Altinbas A, et al. Thrombopoietin and mean platelet volume in coronary artery disease. Clin Cardiol 2001; 24: 405-408.
29. Smyth DW, Martin JF, Michalis L, et al. Influence of platelet size before coronary angioplasty on subsequent restenosis. Eur J Clin Invest 1993; 23: 361-367.
30. Yang A, Pizzulli L, Luderitz B. Mean platelet volume as marker of restenosis after percutaneous transluminal coronary angioplasty in patients with stable and unstable angina pectoris. Thromb Res 2006; 117: 371-377.
31. Huczek Z, Kochman J, Filipiak KJ, et al. Mean platelet volume on admission predicts impaired reperfusion and long-term mortality in acute myocardial infarction treated with primary percutaneous coronary intervention. J Am Coll Cardiol 2005; 46: 284-290.
32. Gyöngyösi M, Strehblow C, Sperker W, et al. Platelet activation and high tissue factor level predict acute stent thrombosis in pig coronary arteries: prothrombogenic response of drug-eluting or bare stent implantation within the first 24 hours. Thromb Haemost 2006; 96: 202-209.
33. Cay S, Biyikoglu F, Cihan G, et al. Mean platelet volume in the patients with cardiac syndrome X. J Thromb Thrombolysis 2005; 20: 175-178.
34. McShine RL, Sibinga S, Brozovic B. Differences between the effects of EDTA and citrate anticoagulants on platelet count and mean platelet volume. Clin Lab Haematol 1990; 12: 277-285.
35. Smith NM, Pathansali R, Bath PM. Platelets and stroke. Vasc Med 1999; 4: 165-172.
36. Hartwig JH. The platelet: form and function. Semin Hematol 2006; 43: S94-100.
37. Bancroft AJ, Abel EW, Mclaren M, et al. Mean platelet volume is a useful parameter: a reproducible routine method using a modified Coulter thrombocytometer. Platelets 2000; 11: 379-387.
38. Kaushansky K, Drachman JG. The molecular and cellular biology of thrombopoietin: the primary regulator of platelet production. Oncogene 2002; 21: 3359-3367.
39. Kuter DJ, Rosenberg. The reciprocal relationship of thrombopoietin (c-Mpl ligand) to changes in the platelet mass during busulfan-induced thrombocytopenia in the rabbit. Blood 1995; 85: 2720-2730.
40. Metcalf D, Burgess AW, Johnson GR, et al. In vitro actions on hemopoietic cells of recombinant murine GM-CSF purified after production in Escherichia coli: comparison with purified native GM-CSF. J Cell Physiol 1986; 128: 421-431.
41. Kimura H, Ishibashi T, Shikama Y, et al. Interleukin-1 beta (IL-1 beta) induces thrombocytosis in mice: possible implication of IL-6. Blood 1990; 76: 2493-2500.
42. Debili N, Masse JM, Katz A, et al. Effects of the recombinant hematopoietic growth factors interleukin-3, interleukin-6, stem cell factor, and leukemia inhibitory factor on the megakaryocytic differentiation of CD34+ cells. Blood 1993; 82: 84-95.
43. Leonard JP, Quinto CM, Kozitza MK, et al. Recombinant human interleukin-11 stimulates multilineage hematopoietic recovery in mice after a myelosuppressive regimen of sublethal irradiation and carboplatin. Blood 1994; 83: 1499-1506.
44. Battinelli E, Willoughby SR, Foxall T, et al. Induction of platelet formation from megakaryocytoid cells by nitric oxide. Proc Natl Acad Sci USA 2001; 98: 14458-14463.
45. Mukaida N. Interleukin-8: an expanding universe beyond neutrophil chemotaxis and activation. Int J Hematol 2000; 72: 391-398.
46. Jurcut R, Arsenescu I, Puscariu T, et al. Is interleukin-18 correlated with endothelial dysfunction and platelet activation in patients with unstable angina? Rom J Intern Med 2005; 43: 199-209.
47. Lefer AM, Ma XL. Cytokines and growth factors in endothelial dysfunction. Crit Care Med 1993; 21: S9-14.
48. Robinson SD, Harding SA, Cummins P, et al. Functional interplay between platelet activation and endothelial dysfunction in patients with coronary heart disease. Platelets 2006; 17: 158-162.
49. Gawaz M, Langer H, May AE. Platelets in inflammation and atherogenesis. J Clin Invest 2005; 115: 3378-3384.
50. Rondinone CM. Adipocyte-derived hormones, cytokines, and mediators. Endocrine 2006; 29: 81-90.